|
AK3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.395540E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.033800E-02 |
| Normal-vs-Stage2 |
2.867400E-01 |
| Normal-vs-Stage3 |
8.135900E-03 |
| Normal-vs-Stage4 |
4.46619999999731E-05 |
| Stage1-vs-Stage2 |
5.892200E-01 |
| Stage1-vs-Stage3 |
2.488400E-01 |
| Stage1-vs-Stage4 |
9.142500E-03 |
| Stage2-vs-Stage3 |
2.321200E-01 |
| Stage2-vs-Stage4 |
1.884440E-02 |
| Stage3-vs-Stage4 |
1.215430E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.275200E-03 |
| Normal-vs-AfricanAmerican |
9.827400E-01 |
| Normal-vs-Asian |
4.500500E-03 |
| Caucasian-vs-AfricanAmerican |
5.874400E-02 |
| Caucasian-vs-Asian |
4.298200E-01 |
| AfricanAmerican-vs-Asian |
3.395700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.070200E-02 |
| Normal-vs-Female |
1.417810E-02 |
| Male-vs-Female |
9.556400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.047900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.623970E-02 |
| Normal-vs-Age(61-80Yrs) |
3.205800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.859850E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.404800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.827400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.838590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.009400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.564200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.054200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.049600E-02 |
| Classical-VS-Follicular |
9.124000E-01 |
| Classical-VS-Other |
6.178600E-01 |
| Classical-VS-Normal |
5.155600E-02 |
| Tall-VS-Follicular |
5.124300E-02 |
| Tall-VS-Other |
5.348800E-01 |
| Tall-VS-Normal |
8.424700E-04 |
| Follicular-VS-Other |
7.003400E-01 |
| Follicular-VS-Normal |
8.656200E-02 |
| Other-VS-Normal |
1.807600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.815630E-02 |
| Normal-vs-N1 |
4.44419999999779E-05 |
| N0-vs-N1 |
1.557970E-02 |
|
|
